FDA oversight :
blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.

Description

Corporate Author

United States. Congress.

Language(s)

English

Published

Washington : U.S. G.P.O. : 1998.

Subjects

Blood > Blood / Collection and preservation > Blood / Collection and preservation / Safety regulations > Blood / Collection and preservation / Safety regulations / United States.
Blood plasma > Blood plasma / Safety regulations > Blood plasma / Safety regulations / United States.
Plasma products > Plasma products / Safety regulations > Plasma products / Safety regulations / United States.

Note

"Serial no. 105-70."
Shipping list no.: 98-0150-P.
Distributed to some depository libraries in microfiche.

Physical Description

iii, 427 p. : ill. ; 24 cm.

ISBN

0160561035

Locate a Print Version

Find in a library

Viewability